← Back to Search

Other

Laser Treatment for Basal Cell Carcinoma

N/A
Waitlist Available
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-15 months after treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effect of using a laser to treat basal cell carcinoma under the guidance of imaging modalities.

Who is the study for?
This trial is for adults with a confirmed diagnosis of superficial or nodular basal cell carcinoma (BCC) that's less than 2.0 cm wide. Participants must be willing to have photos taken and follow instructions, or have someone who can do so on their behalf. Pregnant individuals, those needing surgical excision, unable to commit to a full year of follow-up, unwilling to undergo biopsy, or with herpes in the treatment area cannot join.
What is being tested?
The study tests Nd:YAG laser treatment guided by OCT imaging for BCC removal. It aims to improve precision in targeting cancer cells while monitoring clearance through advanced imaging techniques like OCT and RCM. The main goal is complete cancer removal verified by clinical exams and biopsies.
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include skin irritation, redness, swelling at the treatment site due to laser exposure; precise side effects will be monitored throughout the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-15 months after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-15 months after treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clearance by biopsy
Clearance by imaging

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment of basal cell carcinoma with Nd:YAG laserExperimental Treatment1 Intervention
All enrolled patients will be treated with the Nd:YAG laser for this study as part of the intentional intervention for this study.

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor
311 Previous Clinical Trials
2,176,362 Total Patients Enrolled

Media Library

Nd:YAG Laser (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05138328 — N/A
Basal Cell Carcinoma Research Study Groups: Treatment of basal cell carcinoma with Nd:YAG laser
Basal Cell Carcinoma Clinical Trial 2023: Nd:YAG Laser Highlights & Side Effects. Trial Name: NCT05138328 — N/A
Nd:YAG Laser (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05138328 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top